|
US4816570A
(en)
*
|
1982-11-30 |
1989-03-28 |
The Board Of Regents Of The University Of Texas System |
Biologically reversible phosphate and phosphonate protective groups
|
|
US4649041A
(en)
*
|
1983-07-20 |
1987-03-10 |
Warner-Lambert Company |
Magnesium trisilicate suitable for preparation of medicament adsorbates of antinauseants
|
|
DK159431C
(da)
*
|
1984-05-10 |
1991-03-18 |
Byk Gulden Lomberg Chem Fab |
6-phenyl-3(2h)-pyridazinoner, fremgangsmaade til fremstilling deraf, laegemidler indeholdende disse samt anvendelse af forbindelserne til fremstilling af laegemidler
|
|
US4968788A
(en)
|
1986-04-04 |
1990-11-06 |
Board Of Regents, The University Of Texas System |
Biologically reversible phosphate and phosphonate protective gruops
|
|
US5455339A
(en)
*
|
1986-05-01 |
1995-10-03 |
University Of Georgia Research Foundation, Inc. |
Method for the preparation of 2',3'-dideoxy and 2',3'-dideoxydide-hydro nucleosides
|
|
IE63869B1
(en)
|
1986-11-06 |
1995-06-14 |
Res Dev Foundation |
Aerosols containing liposomes and method for their preparation
|
|
FR2611203B1
(fr)
|
1987-02-20 |
1989-06-09 |
Sturtz Georges |
Analogues gem-diphosphoniques d'amethopterine (methotrexate) et de derives deaza-n-10 amethopterine. leur preparation et les compositions pharmaceutiques qui les contiennent
|
|
JP2737191B2
(ja)
*
|
1987-12-28 |
1998-04-08 |
東ソー株式会社 |
均質な石英ガラス塊の製造方法
|
|
US5631370A
(en)
*
|
1988-01-20 |
1997-05-20 |
Regents Of The University Of Minnesota |
Optically-active isomers of dideoxycarbocyclic nucleosides
|
|
US5466793A
(en)
*
|
1988-03-01 |
1995-11-14 |
Ajinomoto Co., Inc. |
Process for preparing 2', 3'- dideoxyinosine
|
|
ZA894534B
(en)
|
1988-06-20 |
1990-03-28 |
Merrell Dow Pharma |
Novel neplanocin derivatives
|
|
US5744600A
(en)
*
|
1988-11-14 |
1998-04-28 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Phosphonomethoxy carbocyclic nucleosides and nucleotides
|
|
CA2001715C
(en)
|
1988-11-14 |
1999-12-28 |
Muzammil M. Mansuri |
Carbocyclic nucleosides and nucleotides
|
|
US5202128A
(en)
*
|
1989-01-06 |
1993-04-13 |
F. H. Faulding & Co. Limited |
Sustained release pharmaceutical composition
|
|
JP2722673B2
(ja)
|
1989-05-31 |
1998-03-04 |
住友化学工業株式会社 |
光学活性なアシルビフェニル誘導体の製造法
|
|
DE4003574A1
(de)
|
1990-02-07 |
1991-08-08 |
Bayer Ag |
Neue dipeptide, verfahren zu ihrer herstellung und ihre verwendung als renininhibitoren in arzneimitteln
|
|
ATE131825T1
(de)
|
1990-06-13 |
1996-01-15 |
Arnold Glazier |
Phosphorylierte prodrugs
|
|
EP0465297B1
(en)
|
1990-07-04 |
1996-01-31 |
Merrell Dow Pharmaceuticals Inc. |
9-Purinyl phosphonic acid derivatives
|
|
US5177064A
(en)
|
1990-07-13 |
1993-01-05 |
University Of Florida |
Targeted drug delivery via phosphonate derivatives
|
|
EP0468119A1
(en)
|
1990-07-24 |
1992-01-29 |
Merrell Dow Pharmaceuticals Inc. |
Novel carbocyclic analogs of certain nucleosides
|
|
US5223618A
(en)
|
1990-08-13 |
1993-06-29 |
Isis Pharmaceuticals, Inc. |
4'-desmethyl nucleoside analog compounds
|
|
EP0481214B1
(en)
*
|
1990-09-14 |
1998-06-24 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Prodrugs of phosphonates
|
|
US5672697A
(en)
|
1991-02-08 |
1997-09-30 |
Gilead Sciences, Inc. |
Nucleoside 5'-methylene phosphonates
|
|
DE4111730A1
(de)
|
1991-04-10 |
1992-10-15 |
Knoll Ag |
Neue cytarabin-derivate, ihre herstellung und verwendung
|
|
JP2648897B2
(ja)
*
|
1991-07-01 |
1997-09-03 |
塩野義製薬株式会社 |
ピリミジン誘導体
|
|
EP0531597A1
(en)
|
1991-09-12 |
1993-03-17 |
Merrell Dow Pharmaceuticals Inc. |
Novel unsaturated acyclic phosphonate derivatives of purine and pyrimidine
|
|
US5610294A
(en)
*
|
1991-10-11 |
1997-03-11 |
The Du Pont Merck Pharmaceutical Company |
Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
|
|
DE4138584A1
(de)
|
1991-11-23 |
1993-05-27 |
Hoechst Ag |
Carbocyclische phosphonat-nucleotidanaloge, deren herstellung und verwendung
|
|
GB9126144D0
(en)
|
1991-12-10 |
1992-02-12 |
British Bio Technology |
Compounds
|
|
FR2692265B1
(fr)
|
1992-05-25 |
1996-11-08 |
Centre Nat Rech Scient |
Composes biologiquement actifs de type phosphotriesters.
|
|
IS2334B
(is)
*
|
1992-09-08 |
2008-02-15 |
Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) |
Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
|
|
DE4308096A1
(de)
|
1993-03-13 |
1994-09-15 |
Hoechst Ag |
Prodrug-Derivate von Enzyminhibitoren mit Hydroxylgruppen, Verfahren zu deren Herstellung und ihre Verwendung
|
|
US5654286A
(en)
*
|
1993-05-12 |
1997-08-05 |
Hostetler; Karl Y. |
Nucleotides for topical treatment of psoriasis, and methods for using same
|
|
ATE199906T1
(de)
|
1993-06-29 |
2001-04-15 |
Mitsubishi Chem Corp |
Phosphonat-nukleotid ester-derivate
|
|
WO1995002582A1
(en)
*
|
1993-07-14 |
1995-01-26 |
Ciba-Geigy Ag |
Cyclic hydrazine compounds
|
|
US5656745A
(en)
|
1993-09-17 |
1997-08-12 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
|
AU691527B2
(en)
|
1993-09-17 |
1998-05-21 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
|
US5446137B1
(en)
*
|
1993-12-09 |
1998-10-06 |
Behringwerke Ag |
Oligonucleotides containing 4'-substituted nucleotides
|
|
US5493030A
(en)
*
|
1994-02-18 |
1996-02-20 |
Syntex (U.S.A.) Inc. |
5-substituted derivatives of mycophenolic acid
|
|
US5854227A
(en)
|
1994-03-04 |
1998-12-29 |
Hartmann; John F. |
Therapeutic derivatives of diphosphonates
|
|
RU2157368C2
(ru)
|
1994-09-26 |
2000-10-10 |
Сионоги Энд Ко., Лтд. |
Производные имидазола и фармацевтическая композиция на их основе
|
|
WO1996014314A2
(en)
|
1994-11-04 |
1996-05-17 |
Gilead Sciences, Inc. |
Thiepane compounds inhibiting and detecting hiv protease
|
|
US5543523A
(en)
|
1994-11-15 |
1996-08-06 |
Regents Of The University Of Minnesota |
Method and intermediates for the synthesis of korupensamines
|
|
ES2097703B1
(es)
*
|
1995-04-12 |
1997-12-01 |
Decox S L |
Una nueva composicion estimulante de la actividad cerebral basada en alcaloides de nucleo de eburnamenina, y sus metodos de preparacion.
|
|
US5747498A
(en)
*
|
1996-05-28 |
1998-05-05 |
Pfizer Inc. |
Alkynyl and azido-substituted 4-anilinoquinazolines
|
|
JPH11508541A
(ja)
|
1995-06-29 |
1999-07-27 |
ノボ ノルディスク アクティーゼルスカブ |
新規な置換アザ二環式化合物
|
|
US5750493A
(en)
*
|
1995-08-30 |
1998-05-12 |
Raymond F. Schinazi |
Method to improve the biological and antiviral activity of protease inhibitors
|
|
EP0852233A4
(en)
|
1995-09-21 |
1999-09-15 |
Nippon Shinyaku Co Ltd |
CYCLOSPORIN PHOSPHATE DERIVATIVES AND MEDICINAL COMPOSITION
|
|
US5914332A
(en)
*
|
1995-12-13 |
1999-06-22 |
Abbott Laboratories |
Retroviral protease inhibiting compounds
|
|
RU2106353C1
(ru)
|
1996-03-19 |
1998-03-10 |
Корпорация "С энд Ти Сайенс энд Текнолоджи Инк." |
Соли 5'-н-фосфоната 3'- азидо-3'-дезокситимидина, являющиеся специфическими ингибиторами продукции вируса иммунодефицита человека вич-1 и вич-2
|
|
US5656746A
(en)
*
|
1996-03-28 |
1997-08-12 |
The Proctor & Gamble Company |
Temporary wet strength polymers from oxidized reaction product of polyhydroxy polymer and 1,2-disubstituted carboxylic alkene
|
|
US5874577A
(en)
*
|
1996-04-03 |
1999-02-23 |
Medichem Research, Inc. |
Method for the preparing 9-12-(Diethoxyphosphonomethoxy)ethyl!adenine and analogues thereof
|
|
US5795909A
(en)
*
|
1996-05-22 |
1998-08-18 |
Neuromedica, Inc. |
DHA-pharmaceutical agent conjugates of taxanes
|
|
CA2261619C
(en)
|
1996-07-26 |
2006-05-23 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
|
US6194398B1
(en)
|
1996-08-13 |
2001-02-27 |
Mitsubishi Chemical Corporation |
Phosphonate nucleotide compound
|
|
EP0948341A4
(en)
|
1996-09-17 |
2003-05-21 |
Supergen Inc |
DERIVATIVES OF PHOSPHOLIPIDE MEDICINES
|
|
JP4118958B2
(ja)
|
1996-10-09 |
2008-07-16 |
ファーマセット，リミティド |
テトラホスホネート二環式トリス無水物
|
|
JP3378016B2
(ja)
*
|
1996-12-26 |
2003-02-17 |
塩野義製薬株式会社 |
カルバモイル基を有するイミダゾール誘導体の製造法
|
|
WO1999029702A2
(en)
|
1997-12-10 |
1999-06-17 |
The Government Of The United States Of America Reppresented By The Secretary, Department Of Health And Human Services |
METHOD FOR SYNTHESIZING 9-(2,3-DIDEOXY-2-FLUORO-β-D-THREO-PENTOFURANOSYL)ADENINE (β-FddA)
|
|
US6436989B1
(en)
|
1997-12-24 |
2002-08-20 |
Vertex Pharmaceuticals, Incorporated |
Prodrugs of aspartyl protease inhibitors
|
|
US6312662B1
(en)
*
|
1998-03-06 |
2001-11-06 |
Metabasis Therapeutics, Inc. |
Prodrugs phosphorus-containing compounds
|
|
US6174888B1
(en)
*
|
1998-05-28 |
2001-01-16 |
Novartis Ag |
2-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydropyrrolo[3,2-D]pyrimidin-4-ones
|
|
AU4125099A
(en)
|
1998-06-01 |
1999-12-20 |
S & T Science And Technology Inc. |
Antiviral phosphorus derivatives of 4'-thio-5-ethyl-2'-deoxyuridine
|
|
GB9815567D0
(en)
|
1998-07-18 |
1998-09-16 |
Glaxo Group Ltd |
Antiviral compound
|
|
TWI260322B
(en)
*
|
1999-02-12 |
2006-08-21 |
Vertex Pharma |
Inhibitors of aspartyl protease
|
|
US6761903B2
(en)
*
|
1999-06-30 |
2004-07-13 |
Lipocine, Inc. |
Clear oil-containing pharmaceutical compositions containing a therapeutic agent
|
|
HUP0200260A3
(en)
|
1999-03-05 |
2002-11-28 |
Metabasis Therapeutics Inc San |
Novel phosphorus-containing prodrugs, their preparation and their use
|
|
DE19912636A1
(de)
|
1999-03-20 |
2000-09-21 |
Aventis Cropscience Gmbh |
Bicyclische Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide und pharmazeutische Mittel
|
|
US6258831B1
(en)
*
|
1999-03-31 |
2001-07-10 |
The Procter & Gamble Company |
Viral treatment
|
|
US6608027B1
(en)
*
|
1999-04-06 |
2003-08-19 |
Boehringer Ingelheim (Canada) Ltd |
Macrocyclic peptides active against the hepatitis C virus
|
|
DE19927689A1
(de)
*
|
1999-06-17 |
2000-12-21 |
Gruenenthal Gmbh |
Orale Darreichungsformen zur Verabreichung einer fixen Kombination von Tramadol und Diclofenac
|
|
CA2377278C
(en)
*
|
1999-06-25 |
2010-03-23 |
Vertex Pharmaceuticals Incorporated |
Prodrugs of carbamate inhibitors of impdh
|
|
US6581606B2
(en)
*
|
1999-07-06 |
2003-06-24 |
The Rx Files Corporation |
Method, apparatus and system for use in treating patient with a drug having an antineoplastic effect to optimize therapy and prevent an adverse drug response
|
|
CA2381425A1
(en)
|
1999-08-24 |
2001-03-01 |
Cellgate, Inc. |
Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties
|
|
GB9920872D0
(en)
|
1999-09-04 |
1999-11-10 |
Glaxo Group Ltd |
Benzophenones as inhibitors of reverse transcriptase
|
|
IL131887A0
(en)
|
1999-09-14 |
2001-03-19 |
Dpharm Ltd |
Phospholipid prodrugs of anti-proliferative drugs
|
|
DE60038038T2
(de)
|
1999-12-03 |
2009-02-12 |
The Regents of The University of California at San Diego, La Jolla |
Phosphonatverbindungen
|
|
WO2001046204A1
(en)
|
1999-12-22 |
2001-06-28 |
Merck Frosst Canada & Co. |
Aromatic phosphonates as protein tyrosine phosphatase 1b (ptp-1b) inhibitors
|
|
WO2001064693A1
(fr)
|
2000-02-29 |
2001-09-07 |
Mitsubishi Pharma Corporation |
Compose de nucleotide de phosphonate
|
|
MY164523A
(en)
*
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
|
IL153363A0
(en)
|
2000-06-13 |
2003-07-06 |
Shionogi & Co |
Pharmaceutical compositions containing propenone derivatives
|
|
FR2810322B1
(fr)
|
2000-06-14 |
2006-11-10 |
Pasteur Institut |
PRODUCTION COMBINATOIRE D'ANALOGUES DE NUCLEOTIDES ET NUCLEOTIDES (XiTP)
|
|
UA72612C2
(en)
|
2000-07-06 |
2005-03-15 |
|
Pyrido[2.3-d]pyrimidine and pyrimido[4.5-d]pyrimidine nucleoside analogues, prodrugs and method for inhibiting growth of neoplastic cells
|
|
US6617310B2
(en)
|
2000-07-19 |
2003-09-09 |
Bristol-Myers Squibb Pharma Company |
Phosphate esters of bis-amino acid sulfonamides containing substituted benzyl amines
|
|
CZ304734B6
(cs)
|
2000-07-21 |
2014-09-10 |
Gilead Sciences, Inc. |
Způsob přípravy 9-[2-(fosfonomethoxy)propyl]adeninu a 9-[2-(fosfonomethoxy)ethyl]adeninu
|
|
US6420586B1
(en)
|
2000-08-15 |
2002-07-16 |
University Of Kansas |
Amino acid-derived cyclic phosphonamides and methods of synthesizing the same
|
|
WO2002020010A1
(en)
*
|
2000-09-08 |
2002-03-14 |
Zeria Pharmaceutical Co., Ltd. |
Pharmaceutical compositions containing aminothiazole derivatives for the treatment of colonic motor dysfunctions
|
|
RU2188203C2
(ru)
|
2000-10-05 |
2002-08-27 |
Государственный научный центр вирусологии и биотехнологии "Вектор" |
2',3'-дидегидро-2',3'-дидезокситимидин-5'[(этоксикарбонил)(этил)фосфонат]- ингибитор репродукции вируса иммунодефицита человека
|
|
GB0028429D0
(en)
*
|
2000-11-22 |
2001-01-10 |
Astrazeneca Ab |
Therapy
|
|
WO2002048165A2
(en)
|
2000-12-15 |
2002-06-20 |
Pharmasset Ltd. |
Antiviral agents for treatment of flaviviridae infections
|
|
PL209375B1
(pl)
*
|
2000-12-28 |
2011-08-31 |
Kissei Pharmaceutical |
Pochodne glukopiranozyloksypirazolu, kompozycja farmaceutyczna zawierająca takie pochodne i zastosowanie tych pochodnych do wytwarzania kompozycji farmaceutycznej
|
|
WO2002057425A2
(en)
|
2001-01-22 |
2002-07-25 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
|
MXPA03005403A
(es)
*
|
2001-01-31 |
2003-09-25 |
Warner Lambert Co |
Metodo para carbamoilar alcoholes.
|
|
EP1864967A1
(en)
*
|
2001-02-12 |
2007-12-12 |
Wyeth |
Method for preparing O-desmethyl-venlafaxine
|
|
US6962684B2
(en)
*
|
2001-05-31 |
2005-11-08 |
Sumitomo Chemical Company, Limited |
Activated alumina formed body and method for producing the same
|
|
GB0114286D0
(en)
|
2001-06-12 |
2001-08-01 |
Hoffmann La Roche |
Nucleoside Derivatives
|
|
ATE371026T1
(de)
|
2001-06-20 |
2007-09-15 |
Nuevolution As |
Eine methode zur synthese von matrizenabhängigen molekülen
|
|
KR20020097384A
(ko)
*
|
2001-06-20 |
2002-12-31 |
미쯔비시 도꾜 세이야꾸 가부시끼가이샤 |
기존의 약제에 내성변이를 가지는 바이러스에 유효한 약제
|
|
ATE411805T1
(de)
*
|
2001-07-20 |
2008-11-15 |
Bioagency Ag |
Organo-phosphorverbindungen zur aktivierung von gamma/delta-t-zellen
|
|
KR100879693B1
(ko)
*
|
2001-08-17 |
2009-01-21 |
상꾜 아그로 가부시키가이샤 |
2-시클로프로필-6-메틸페놀
|
|
WO2003028737A1
(en)
|
2001-08-30 |
2003-04-10 |
Mitsubishi Pharma Corporation |
Anti-viral agents and in-vitro method for the identification of candidates able to inhibit binding of polymerase to epsilon
|
|
EP1461040B1
(en)
*
|
2001-11-29 |
2006-03-15 |
Pfizer Products Inc. |
Succinic acid salts of 5,8,14-triazatetracyclo[10.3.1.0 2,11 .0 4,9 ]-hexadeca-2(11),3,5,7,9,-pentaene and pharmaceutical compositions thereof
|
|
AU2002343556A1
(en)
|
2001-12-07 |
2003-06-23 |
Eli Lilly And Company |
Use of phosphonate nucleotide analogue for treating hepatitis b virus infections
|
|
GEP20063872B
(en)
*
|
2001-12-12 |
2006-07-10 |
Pfizer Prod Inc |
Salt forms of e-2-methoxy-n-(3-{4-[3-methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quina-zolin-6-yl}-allyl)-acetamide and method of production
|
|
KR101016969B1
(ko)
|
2001-12-21 |
2011-02-25 |
에이자이 아이엔씨. |
알콜 및 페놀의 수용성 포스포노옥시메틸 유도체를제조하는 방법
|
|
US20030198666A1
(en)
*
|
2002-01-07 |
2003-10-23 |
Richat Abbas |
Oral insulin therapy
|
|
JP4547911B2
(ja)
|
2002-02-01 |
2010-09-22 |
アリアド・ファーマシューティカルズ・インコーポレイテッド |
リン含有化合物およびその用途
|
|
EP1472230B1
(en)
|
2002-02-08 |
2009-06-17 |
Conforma Therapeutic Corporation |
Ansamycins having improved pharmacological and biological properties
|
|
US7927613B2
(en)
*
|
2002-02-15 |
2011-04-19 |
University Of South Florida |
Pharmaceutical co-crystal compositions
|
|
WO2003080078A1
(en)
|
2002-03-18 |
2003-10-02 |
Mitsubishi Pharma Corporation |
Treatment of pre-core hepatitis b virus mutant infections
|
|
WO2003087090A2
(en)
*
|
2002-04-10 |
2003-10-23 |
Ortho-Mcneil Pharmaceutical,Inc. |
Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
|
|
AU2003231765B9
(en)
|
2002-04-26 |
2010-01-28 |
Gilead Sciences, Inc. |
Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds and the compounds as such
|
|
US20050239054A1
(en)
|
2002-04-26 |
2005-10-27 |
Arimilli Murty N |
Method and compositions for identifying anti-HIV therapeutic compounds
|
|
US6872827B2
(en)
*
|
2002-04-26 |
2005-03-29 |
Chembridge Research Laboratories, Inc. |
Somatostatin analogue compounds
|
|
US6808572B2
(en)
*
|
2002-05-15 |
2004-10-26 |
Aerojet-General Corporation |
Solid propellant formulations and methods and devices employing the same for the destruction of airborne biological and/or chemical agents
|
|
EP1546138B1
(en)
|
2002-09-30 |
2012-01-18 |
A/S GEA Farmaceutisk Fabrik |
Raloxifene l-lactate or a hemihydrate thereof, their uses, pharmaceutical compositions and preparation processes
|
|
US20040157793A1
(en)
*
|
2002-11-12 |
2004-08-12 |
Stuyver Lieven J. |
Modified nucleosides as antiviral agents
|
|
EA012844B1
(ru)
*
|
2003-02-19 |
2009-12-30 |
Йельский Университет |
Аналоги противовирусных нуклеозидов и способы лечения вирусных инфекций, в частности вич-инфекций
|
|
WO2004100960A2
(en)
|
2003-04-25 |
2004-11-25 |
Gilead Sciences, Inc. |
Anti-inflammatory phosphonate compounds
|
|
US7273716B2
(en)
|
2003-04-25 |
2007-09-25 |
Gilead Sciences, Inc. |
Methods and compositions for identifying therapeutic compounds with GS-7340 ester hydrolase
|
|
US7432261B2
(en)
|
2003-04-25 |
2008-10-07 |
Gilead Sciences, Inc. |
Anti-inflammatory phosphonate compounds
|
|
CN101410120A
(zh)
|
2003-04-25 |
2009-04-15 |
吉里德科学公司 |
抗炎的膦酸酯化合物
|
|
WO2004096233A2
(en)
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Nucleoside phosphonate conjugates
|
|
WO2004096287A2
(en)
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
|
|
EP2359833A1
(en)
|
2003-04-25 |
2011-08-24 |
Gilead Sciences, Inc. |
Antiviral phosphonate analogs
|
|
US7470724B2
(en)
|
2003-04-25 |
2008-12-30 |
Gilead Sciences, Inc. |
Phosphonate compounds having immuno-modulatory activity
|
|
US7452901B2
(en)
*
|
2003-04-25 |
2008-11-18 |
Gilead Sciences, Inc. |
Anti-cancer phosphonate analogs
|
|
WO2004096235A2
(en)
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Anti-cancer phosphonate analogs
|
|
US7407965B2
(en)
|
2003-04-25 |
2008-08-05 |
Gilead Sciences, Inc. |
Phosphonate analogs for treating metabolic diseases
|
|
WO2005002626A2
(en)
|
2003-04-25 |
2005-01-13 |
Gilead Sciences, Inc. |
Therapeutic phosphonate compounds
|
|
NZ542343A
(en)
|
2003-04-25 |
2009-03-31 |
Gilead Sciences Inc |
Immunomodulator phosphonate conjugates
|
|
US7300924B2
(en)
|
2003-04-25 |
2007-11-27 |
Gilead Sciences, Inc. |
Anti-infective phosphonate analogs
|
|
MXPA05011296A
(es)
|
2003-04-25 |
2006-01-24 |
Gilead Sciences Inc |
Conjugados de fosfonato inhibidores de la cinasa.
|
|
WO2004096237A2
(en)
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Phosphonate analogs for treating metabolic diseases
|
|
WO2005000786A1
(en)
|
2003-05-23 |
2005-01-06 |
Transform Pharmaceuticals, Inc. |
Sertraline compositions
|
|
EP1634882A4
(en)
*
|
2003-06-16 |
2008-01-09 |
Ajinomoto Kk |
INOSIN DERIVATIVE AND METHOD FOR THE PRODUCTION THEREOF
|
|
AU2004260789B2
(en)
|
2003-07-30 |
2011-06-30 |
Gilead Sciences, Inc. |
Nucleobase phosphonate analogs for antiviral treatment
|
|
BRPI0413595B8
(pt)
*
|
2003-08-18 |
2021-05-25 |
H Lundbeck As |
sal de malonato, composição farmacêutica, uso de um sal de malonato, e, método de fabricação de um composto
|
|
US7427624B2
(en)
|
2003-10-24 |
2008-09-23 |
Gilead Sciences, Inc. |
Purine nucleoside phosphorylase inhibitory phosphonate compounds
|
|
WO2005044308A1
(en)
|
2003-10-24 |
2005-05-19 |
Gilead Sciences, Inc. |
Phosphonate analogs of antimetabolites
|
|
WO2005063751A1
(en)
|
2003-12-22 |
2005-07-14 |
Gilead Sciences, Inc. |
4’-substituted carbovir-and abacavir-derivatives as well as related compounds with hiv and hcv antiviral activity
|
|
CA2548951A1
(en)
|
2003-12-22 |
2005-07-14 |
Gilead Sciences, Inc. |
Kinase inhibitor phosphonate conjugates
|
|
US20050171126A1
(en)
*
|
2003-12-26 |
2005-08-04 |
Ajinomoto Co., Inc. |
Process for the production of purine nucleoside compounds
|
|
US7404949B2
(en)
*
|
2004-03-15 |
2008-07-29 |
Unilever Home & Personal Care Usa, Division Of Conopco, Inc. |
Methods and compositions useful to prevent in-grown hair arising from shaving
|
|
US20090035315A1
(en)
*
|
2004-06-17 |
2009-02-05 |
Stephan Christgau |
Method of Improving Treatments in Rheumatic and Arthritic Diseases
|
|
ME03423B
(me)
*
|
2004-07-27 |
2020-01-20 |
Gilead Sciences Inc |
Fosfonatni analozi jedinjenja hiv inhibitora
|
|
WO2006015262A2
(en)
|
2004-07-29 |
2006-02-09 |
Coherix, Inc. |
Method for processing multiwavelength interferometric imaging data
|
|
US20060069060A1
(en)
*
|
2004-09-27 |
2006-03-30 |
Sanjeev Redkar |
Salts of decitabine
|
|
US7154505B2
(en)
|
2004-11-11 |
2006-12-26 |
Stonecube Limited |
Method of and apparatus for generating a representation of an object
|
|
KR20060080817A
(ko)
*
|
2005-01-06 |
2006-07-11 |
씨제이 주식회사 |
시부트라민의 디카복실산염
|
|
MY148074A
(en)
*
|
2005-05-10 |
2013-02-28 |
Novartis Ag |
Pharmaceutical compositions comprising imatinib and a release retardant
|
|
AU2006278596A1
(en)
*
|
2005-08-04 |
2007-02-15 |
Novartis Ag |
Salts of vildagliptin
|
|
DE102005041860A1
(de)
*
|
2005-09-02 |
2007-03-08 |
Schering Ag |
Nanopartikulärer Einschluss- und Ladungskomplex für pharmazeutische Formulierungen
|
|
JP2009519952A
(ja)
*
|
2005-12-16 |
2009-05-21 |
ワイス |
トリアゾロピリミジン化合物の凍結乾燥組成物
|
|
US20060223820A1
(en)
*
|
2006-03-21 |
2006-10-05 |
Chemagis Ltd. |
Crystalline aripiprazole salts and processes for preparation and purification thereof
|
|
US8895531B2
(en)
*
|
2006-03-23 |
2014-11-25 |
Rfs Pharma Llc |
2′-fluoronucleoside phosphonates as antiviral agents
|
|
JP5243413B2
(ja)
*
|
2006-05-26 |
2013-07-24 |
スリーディー システムズ インコーポレーテッド |
３次元プリンターで材料を処理する装置と方法
|
|
PL3150586T3
(pl)
*
|
2007-02-23 |
2020-06-01 |
Gilead Sciences, Inc. |
Modulatory farmakokinetycznych właściwości środków terapeutycznych
|
|
US20090163449A1
(en)
*
|
2007-12-20 |
2009-06-25 |
Eastman Chemical Company |
Sulfo-polymer powder and sulfo-polymer powder blends with carriers and/or additives
|
|
UA103329C2
(ru)
*
|
2008-07-08 |
2013-10-10 |
Гилиад Сайенсиз, Инк. |
Соли соединений-ингибиторов вич
|
|
JP4330086B1
(ja)
|
2009-02-09 |
2009-09-09 |
株式会社テクネス |
非酸化物セラミックス製品の製造方法
|
|
EP2305680A3
(en)
|
2009-09-30 |
2011-05-18 |
Aurobindo Pharma Limited |
Novel salts of (1S,4R)-cis-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol
|
|
WO2014055618A1
(en)
|
2012-10-03 |
2014-04-10 |
Gilead Sciences, Inc. |
Solid state forms of hiv inhibitor: hemi-succinate of (2s)-2-tert-butoxy-2-(4-(2,3-dihydropyrano[4,3,2-de]quinolin-7-yl)-2-methylquinolin-3-yl)acetic acid)
|
|
US20140094609A1
(en)
|
2012-10-03 |
2014-04-03 |
Gilead Sciences, Inc. |
Process for the preparation of an hiv integrase inhibitor
|